Please provide your email address to receive an email when new articles are posted on . Five out of six patients had a 1.3-fold increase in PFS with the approach vs. their previous regimen. The ...
Please provide your email address to receive an email when new articles are posted on . Maria Lalouni, of Karolinska Insitutet in Sweden, said although cognitive behavioral therapy (CBT) has shown ...
NeurAxis's PENFS technology is recommended for treating pediatric Functional Abdominal Pain in newly published guidelines, enhancing insurance coverage potential. NeurAxis, Inc. has announced that its ...
Functional seizures are a type of functional neurological disorder, or FND, that also goes by the name conversion disorder. It means “any neurological symptom incompatible with a known medical or ...
BOSTON, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial evaluating LINZESS (linaclotide) 72 mcg in ...
Each year, about 20 % of the 70 million people who are evaluated in epilepsy clinics turn out to have seizures that cannot be identified by any physical cause in the brain. The trouble, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback